BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  G1 Therapeutics Provides Third Quarter 2019 Corporate and Financial Update

  G1 Therapeutics, Inc., a clinical-stage oncology company, provided a corporate and financial update for the third quarter ended September 30, 2019.

  November 5, 2019

   · 

  7 min read
• Biotech Bay

  Fluidigm Drives a New Standard in Human Immune ProfilingMore than 100 Academic, Pharmaceutical and Biotech Companies Select Maxpar Immune Profiling Panels Using CyTOF Technology to Accelerate Translational and Clinical Research

  Fluidigm Corporation announced it has exceeded $1 million in revenue from its industry-leading Maxpar® Direct™ Immune Profiling Assay™ and Maxpar Human Immune Monitoring Panel Kit.

  November 5, 2019

   · 

  3 min read
• Biotech Bay

  Silk Road Medical to Present at the Stifel 2019 Healthcare Conference

  Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced the company will be participating in the upcoming Stifel 2019 Healthcare Conference in New York, NY.

  November 5, 2019

   · 

  1 min read
• Business

  Kura Oncology Reports Third Quarter 2019 Financial Results and Provides Corporate Update

  Updated data from Phase 2 trial of tipifarnib in HRAS mutant HNSCC support enrichment strategy in ongoing registration-directed trial

  November 5, 2019

   · 

  12 min read
• Business

  Conatus Pharmaceuticals Reports Third Quarter 2019 Financial Results

  Conatus Pharmaceuticals Inc. announced financial results for the quarter and nine months ended September 30, 2019..

  November 5, 2019

   · 

  5 min read
• Business

  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Third Quarter Ended September 30, 2019

  GW Pharmaceuticals plc announces financial results for the third quarter ended September 30, 2019.

  November 5, 2019

   · 

  10 min read
• Business

  Synthorx Reports Third Quarter 2019 Financial Results

  Synthorx, Inc. reported financial results and provided a business update for the third quarter ended September 30, 2019.

  November 5, 2019

   · 

  8 min read
• Business

  Recro Pharma to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 8, 2019Conference Call and Webcast Scheduled for Friday, November 8, 2019 at 8:00 a.m. ET

  Recro Pharma, Inc. announced that it will report third quarter financial results on Friday, November 8, 2019. Recro’s management team will host a conference call and audio webcast at 8:00 a.m. ET on Friday, November 8, 2019 to discuss the financial results and recent operational highlights..

  November 5, 2019

   · 

  2 min read
• Business

  Fluidigm Announces Third Quarter 2019 Financial Results

  Third quarter revenue decreased 8.5 percent to $26.5 million; year-to-date revenue increased 5 percent to $84.8 million

  November 5, 2019

   · 

  17 min read
• Business

  OPKO Health Reports 2019 Third Quarter Business Highlights and Financial ResultsConference call begins at 4:30 p.m. Eastern time today

  OPKO Health, Inc. reports business highlights and financial results for the three months ended September 30, 2019..

  November 5, 2019

   · 

  10 min read